home / stock / fusn / fusn quote
Last: | $21.55 |
---|---|
Change Percent: | 0.0% |
Open: | $21.55 |
Close: | $21.55 |
High: | $21.59 |
Low: | $21.45 |
Volume: | 6,089,181 |
Last Trade Date Time: | 06/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$21.55 | $21.55 | $21.55 | $21.59 | $21.45 | 6,089,181 | 06-03-2024 |
$21.52 | $21.5 | $21.52 | $21.6 | $21.46 | 952,407 | 05-31-2024 |
$21.47 | $21.43 | $21.47 | $21.5 | $21.38 | 3,961,572 | 05-30-2024 |
$21.41 | $21.45 | $21.41 | $21.47 | $21.41 | 1,390,044 | 05-29-2024 |
$21.45 | $21.48 | $21.45 | $21.51 | $21.45 | 1,085,229 | 05-28-2024 |
$21.48 | $21.5 | $21.48 | $21.53 | $21.46 | 420,683 | 05-27-2024 |
$21.48 | $21.5 | $21.48 | $21.53 | $21.46 | 420,683 | 05-24-2024 |
$21.5 | $21.53 | $21.5 | $21.56 | $21.48 | 801,535 | 05-23-2024 |
$21.52 | $21.53 | $21.52 | $21.54 | $21.49 | 148,952 | 05-22-2024 |
$21.49 | $21.48 | $21.49 | $21.545 | $21.48 | 211,132 | 05-21-2024 |
$21.53 | $21.5 | $21.53 | $21.55 | $21.45 | 342,824 | 05-20-2024 |
$21.51 | $21.52 | $21.51 | $21.52 | $21.45 | 183,610 | 05-17-2024 |
$21.46 | $21.54 | $21.46 | $21.54 | $21.46 | 277,607 | 05-16-2024 |
$21.54 | $21.45 | $21.54 | $21.54 | $21.45 | 474,825 | 05-15-2024 |
$21.43 | $21.45 | $21.43 | $21.455 | $21.42 | 247,019 | 05-14-2024 |
$21.43 | $21.41 | $21.43 | $21.47 | $21.41 | 133,365 | 05-13-2024 |
$21.48 | $21.4 | $21.48 | $21.5 | $21.35 | 383,838 | 05-10-2024 |
$21.38 | $21.38 | $21.38 | $21.45 | $21.38 | 264,014 | 05-09-2024 |
$21.4 | $21.42 | $21.4 | $21.45 | $21.35 | 563,091 | 05-08-2024 |
$21.4 | $21.45 | $21.4 | $21.47 | $21.38 | 726,511 | 05-07-2024 |
News, Short Squeeze, Breakout and More Instantly...
Fusion Pharmaceuticals Inc. Company Name:
FUSN Stock Symbol:
NASDAQ Market:
Fusion Pharmaceuticals Inc. Website:
Acquisition of Fusion Pharmaceuticals Completed Canada NewsWire HAMILTON , ON and BOSTON , June 4, 2024 /CNW/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radioconjugates (RCs), a...
Fusion Pharmaceuticals Receives Final Court Order Approving Arrangement Canada NewsWire HAMILTON , ON and BOSTON , May 31, 2024 /CNW/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation ...
Fusion Pharmaceuticals Shareholders Approve Acquisition by AstraZeneca Canada NewsWire HAMILTON, ON and BOSTON , May 29, 2024 /CNW/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiocon...